IFNA1 and chronic myelogenous leukemia, BCR-ABL1 positive: The proportion of CD3+ T-cells from total lymphocyte population was decreased in both CML patient groups when compared to healthy volunteers (67% in IFN-ON, 56% in IFN-OFF vs. 73% in healthy controls, p = 0.0002)(Figure 1A, Table S1).